[05 November 2013]
Products Affected - Description
Isoniazid Tablets, Versapharm
100 mg, 100 count (NDC 61748-0016-01)
300 mg, 30 count (NDC 61748-0013-30)
300 mg, 100 count (NDC 61748-0013-01)
300 mg, 1000 count (NDC 61748-0013-10)
Isoniazid Tablets, West-Ward
100 mg, 100 count (NDC 00143-1260-01)
100 mg, 1000 count (NDC 00143-1260-10)
300 mg, 100 count (NDC 00143-1261-01)
300 mg, 1000 count (NDC 00143-1261-10)
Reason for the Shortage
Mylan Institutional, Sandoz, Versapharm, and West-Ward could not provide a reason for the shortage.
Isoniazid Tablets, Mylan Institutional
300 mg, 100 count unit-dose (NDC 51079-0083-20)
Isoniazid Tablets, Sandoz
100 mg, 30 count (NDC 00185-4351-30)
100 mg, 100 count (NDC 00185-4351-01)
100 mg, 1000 count (NDC 00185-4351-10)
300 mg, 30 count (NDC 00185-4350-30)
300 mg, 100 count (NDC 00185-4350-01)
300 mg, 1000 count (NDC 00185-4350-10)
Isoniazid Tablets, Teva
100 mg, 100 count (NDC 00555-0066-02)
100 mg, 1000 count (NDC 00555-0066-05)
300 mg, 30 count (NDC 00555-0071-01)
300 mg, 100 count (NDC 00555-0071-02)
300 mg, 1000 count (NDC 00555-0071-05)
Estimated Resupply Dates
- Versapharm has all isoniazid tablets on back order and the company cannot estimate a release date.
- West-Ward has all isoniazid tablets on back order with an estimated release expected in 2014.
November 5, 2013; August 28, 2013; July 16, 2013; June 6, 2013; April 5, 2013; March 5, 2013; February 6, 2013; January 4, 2013, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins